Cannabidiol Overcomes Oxaliplatin Resistance by Enhancing NOS3- and SOD2-Induced Autophagy in Human Colorectal Cancer Cells

Although oxaliplatin is an effective chemotherapeutic drug for colorectal cancer (CRC) treatment, patients often develop resistance to it. Therefore, a new strategy for CRC treatment is needed. The purpose of this study was to determine the effect of cannabidiol (CBD), one of the components of the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Soyeon, Kim, Bu Gyeom, Kim, Dae Yeong, Kim, Bo Ram, Kim, Jung Lim, Park, Seong Hye, Na, Yoo Jin, Jo, Min Jee, Yun, Hye Kyeong, Jeong, Yoon A., Kim, Hong Jun, Lee, Sun Il, Kim, Han Do, Kim, Dae Hyun, Oh, Sang Cheul, Lee, Dae-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627455/
https://www.ncbi.nlm.nih.gov/pubmed/31195721
http://dx.doi.org/10.3390/cancers11060781

Ejemplares similares

Ejemplares similares